|
TCFL5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.243800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.351600E-01 |
| Normal-vs-Stage2 |
8.245400E-01 |
| Normal-vs-Stage3 |
9.219200E-01 |
| Normal-vs-Stage4 |
2.379000E-01 |
| Stage1-vs-Stage2 |
9.064000E-01 |
| Stage1-vs-Stage3 |
9.613600E-01 |
| Stage1-vs-Stage4 |
2.621600E-01 |
| Stage2-vs-Stage3 |
8.976200E-01 |
| Stage2-vs-Stage4 |
3.318800E-01 |
| Stage3-vs-Stage4 |
3.268200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.877800E-01 |
| Normal-vs-AfricanAmerican |
6.524800E-01 |
| Normal-vs-Asian |
7.510400E-01 |
| Caucasian-vs-AfricanAmerican |
6.865000E-01 |
| Caucasian-vs-Asian |
7.784800E-01 |
| AfricanAmerican-vs-Asian |
7.371000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.638800E-01 |
| Normal-vs-Female |
7.760400E-01 |
| Male-vs-Female |
8.757600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.098600E-01 |
| Normal-vs-Extreme_Weight |
7.178000E-01 |
| Normal-vs-Obese |
9.154600E-01 |
| Normal-vs-Extreme_Obese |
4.622400E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.207200E-01 |
| Normal_Weight-vs-Obese |
9.845800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.248760E-01 |
| Extreme_Weight-vs-Obese |
5.976800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.064370E-01 |
| Obese-vs-Extreme_Obese |
1.056960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.702800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.139000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.530800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.760300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.382600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.387000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.774010E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.924150E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.548210E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.250220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.104800E-01 |
| Normal-VS-Type2 PRCC |
3.267700E-02 |
| Normal-VS-KIRP CIMP |
5.532400E-01 |
| Normal-VS-Unclassified PRCC |
5.818200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.430070E-04 |
| Type1 PRCC-VS-KIRP CIMP |
8.994800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.578000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.610000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.255890E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.572600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.170810E-01 |
| Normal-vs-N1 |
1.978400E-01 |
| Normal-vs-N2 |
8.246000E-01 |
| N0-vs-N1 |
5.622200E-02 |
| N0-vs-N2 |
4.141600E-01 |
| N1-vs-N2 |
6.487600E-01 |
|
|
